Clinical Trial Update: Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of bevacizumab, capecitabine, and oxaliplatin in elderly patients with metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Grupo Espanol Multidisciplinario del Cancer Digestivo | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN